Status:

COMPLETED

The Effects of Lycopene on High Risk Prostatic Tissue

Lead Sponsor:

University of Illinois at Chicago

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Intraepithelial Prostatic Neoplasia

Prostatic Neoplasms

Eligibility:

MALE

40+ years

Phase:

PHASE2

Brief Summary

The purpose of this research study is to compare the effects of a lycopene supplement made from tomatoes to a placebo (a capsule with no active ingredients) in men who have abnormal cells in the prost...

Eligibility Criteria

Inclusion

  • Male
  • Have a history of prostate biopsy indicating HGPIN without cancer within 2 years prior to registration. At least 4 weeks must have elapsed between the last biopsy and the biopsy used for baseline data.
  • Have an AUA symptom score \<=25 at time of registration.
  • Refrain from taking lycopene, selenium, vitamin E, or other antioxidant supplements within 1 month of randomization. Participants must agree to refrain from taking non-study dietary supplements while on study
  • Refrain from taking exogenous hormones, drugs affecting hormone metabolism, or specified non-prescription substances (e.g. saw palmetto, PC-Spes) taken to affect the prostate within 1 month of registration. Patients must also agree to refrain from taking the non-prescription substances while on study
  • Be willing to limit intake of lycopene-containing foods while on study
  • Have no prior cancer (except basal cell or squamous cell skin cancer) or complete remission for at least 5 years
  • Be ambulatory, capable of self-care and able to carry out light or sedentary work
  • Have a dietary fat intake of 23-48% of calories
  • Participant's physician recommends repeat biopsy 4-6 months after randomization

Exclusion

  • No repeat biopsy planned
  • Not willing to change diet
  • Have a diagnosis of prostate cancer

Key Trial Info

Start Date :

February 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2009

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT01443026

Start Date

February 1 2006

End Date

April 1 2009

Last Update

November 19 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Northwestern Memorial Hospital

Chicago, Illinois, United States, 60611

2

Jesse Brown VA Medical Center

Chicago, Illinois, United States, 60612